SMPA is deeply committed to accelerating scientific and therapeutic breakthroughs to support patient-first outcomes in areas of critical need, including psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. SMPA aims to address a wide range of indications where treatment options remain limited or nonexistent. By doing so, we strive to make a significant impact on patients’ lives and well-being.